市場調査レポート

中東のFMV(適正市場価格)プロセスおよび医師診察料のスケジュール:明白なHCP(ヘルスケアプロバイダー)関係の構築

Middle East FMV Processes and Physician Fee Schedules: Establishing Transparent HCP Relationships

発行 Cutting Edge Information 商品コード 289839
出版日 ページ情報 英文 104 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
中東のFMV(適正市場価格)プロセスおよび医師診察料のスケジュール:明白なHCP(ヘルスケアプロバイダー)関係の構築 Middle East FMV Processes and Physician Fee Schedules: Establishing Transparent HCP Relationships
出版日: 2013年10月31日 ページ情報: 英文 104 Pages
概要

中東で活動している医療・コンプライアンスチームにとって適正な市場価格(FMV)は依然として大きな未知の領域です。ヘルスケアプロバイダーの報酬のベンチマーキングデータの不足は、FMVプロセスの実行を困難にしています。それに加えて、医薬品企業の主要オピニオンリーダー(KOL)との関係を取り巻く規制要件は限定されており、チームは数多くの国・地域特有の行動規範を解読しなければなりません。さらに、政治・経済力学の変化は路地スティックな問題も生み出しています。

当レポートは、中東におけるFMV(適正市場価格)レート設定に向け、17カ国の一流ライフサイエンス企業からベンチマーキングデータを収集し、チームが重要な目的:明白かつ一貫性のあるFMVフレームワークの構築を達成できるよう提言をまとめており、概略下記の構成でお届けいたします。

エグゼクティブサマリー

  • 調査方法
  • 定義

中東における基本的なFMV(適正市場価格)プラクティス構築のための提言

最小限の規制環境におけるKOL(キーオピニオンリーダー)報酬の決定・公表

  • 適正な市場価格(FMV)を決定するために行動規範・内部プロセスを活用する
  • 政府規制が無い場合は医師の報酬を報告する
  • KOLセグメントのナビゲートおよび中東における選択

中東におけるFMV(適正市場価格)レートのベンチマーキング

  • ヘルスケアプロバイダーの支払い範囲
  • ヘルスケアプロバイダーのFMVを促進する要因
  • 専門ヘルスケアプロバイダーのFMVレート
  • ヘルスケアプロバイダーのFMVレート:活動別

中東のヘルスケアプロバイダー向けの公平な市場額ベンチマーク

図表

目次
Product Code: PH191

For medical and compliance teams operating in the Middle East, fair-market value (FMV) remains largely uncharted territory. First and foremost, a lack of healthcare provider compensation benchmark data makes implementing FMV processes difficult. On top of that, regulatory requirements surrounding pharmaceutical companies' relationships with key opinion leaders (KOLs) are limited, and teams must decipher an array of country- and region-specific codes of conduct. Moreover, shifting political and socioeconomic dynamics create logistical challenges.

This study is a go-to resource for setting FMV rates in the Middle East. Its benchmarking data, collected from top-performing life science firms in 17 countries, will enable teams to achieve key goals:

Establish a clear and consistent FMV framework

The Middle East poses unique challenges that complicate FMV protocols. Our study simplifies this process, outlining five recommendations drawn from industry leaders' experiences. Learn which internal teams to involve in strategy setting and adapt best practices from other regions.

Navigate regulatory hurdles when engaging KOLs

Forward-thinking medical teams incorporate codes of conduct in their internal processes to track and document FMV. Establish new strategies for developing KOL criteria and then use our guidelines and recommendations to avoid pitfalls - including difficult logistics in working with international KOLs - and ensure maximum event impact.

Benchmark compensation rates and compete for top-tier influencers

Compare healthcare provider (HCP) compensation ranges across company type and HCP tier, with benchmarks highlighting maximums and minimums for hourly and half-day flat rates. Our study provides these data for six critical thought leader activities and for specialists and primary care physicians - allowing teams to build rate cards for use across the Middle East.

Table of Contents

Executive Summary

  • Study Methodology
  • Study Definitions

Recommendations for Establishing Fundamental FMV Practices in the Middle East

Determining and Documenting KOL Compensation in a Minimally Regulated Environment

  • Leveraging Codes of Conduct and Internal Processes to Determine Fair- Market Value
  • Reporting Physician Compensation in the Absence of Government Regulations
  • Navigating KOL Segmentation and Selection in the Middle East

Benchmarking Fair-Market Value Rates in the Middle East

  • Healthcare Provider Payment Ranges
  • Factors Driving Healthcare Provider FMV
  • Specialized Healthcare Provider Fair-Market Value Rates
  • Healthcare Provider Fair-Market Value by Activity

Fair-Market Value Benchmarks for Middle East Healthcare Providers

CHARTS AND GRAPHICS

Executive Summary

  • Figure E.1: Average Hourly Rates by Company Type: Tier 1

Recommendations for Establishing Fundamental FMV Practices in the Middle East

Determining and Documenting KOL Compensation in a Minimally Regulated Environment

Leveraging Codes of Conduct and Internal Processes to Determine Fair- Market Value

  • Figure 2.1: Levant and Gulf Countries in the Middle East

Reporting Physician Compensation in the Absence of Government Regulations

Navigating KOL Segmentation and Selection in the Middle East

Benchmarking Fair-Market Value Rates in the Middle East

Healthcare Provider Payment Ranges

  • Figure 3.1: Average Hourly Rates by Company Type, Tier 1
  • Figure 3.2: Average Hourly Rates by Company Type, Tier 2
  • Figure 3.3: Average Hourly Rates by Company Type, Tier 3
  • Figure 3.4: Average Half-Day Flat Rates by Company Type, Tier 1
  • Figure 3.5: Average Half-Day Flat Rates by Company Type, Tier 2

Factors Driving Healthcare Provider FMV

  • Figure 3.6: Average Hourly Rates by Healthcare Provider Tier, Large Pharma
  • Figure 3.7: Average Hourly Rates by Healthcare Provider Activity and Tier, Large Pharma
  • Figure 3.8: Average Half-Day Flat Rates by Healthcare Provider Tier, Large Pharma
  • Figure 3.9: Average Half-Day Flat Rates by Healthcare Provider Activity and Tier, Large Pharma
  • Figure 3.10: Average Hourly Rates by Healthcare Provider Tier, Mid-sized Pharma
  • Figure 3.11: Average Hourly Rates by Healthcare Provider Activity and Tier, Mid-sized Pharma
  • Figure 3.12: Average Half-Day Flat Rates by Healthcare Provider Tier, Mid-sized Pharma
  • Figure 3.13: Average Half-Day Flat Rates by Healthcare Provider Activity and Tier, Mid-sized Pharma
  • Figure 3.14: Average Hourly Rates by Healthcare Provider Tier, Small Pharma
  • Figure 3.15: Average Hourly Rates by Healthcare Provider Activity and Tier, Small Pharma
  • Figure 3.16: Average Hourly Rates by Healthcare Provider Tier, CRO
  • Figure 3.17: Average Hourly Rates by Healthcare Provider Activity and Tier, CRO

Specialized Healthcare Provider Fair-Market Value Rates

  • Figure 3.18: Average Hourly Rates by Healthcare Provider Tier: Specialists
  • Figure 3.19: Average Hourly Rates by Healthcare Provider Tier: Specialists
  • Figure 3.20: Average Hourly Rates by Healthcare Provider Activity and Tier: Specialists
  • Figure 3.21: Average Half-Day Flat Rates by Healthcare Provider Tier, Specialists
  • Figure 3.22: Minimum, Average and Maximum Half-Day Flat Rates by Healthcare Provider Tier, Specialists
  • Figure 3.23: Average Half-Day Flat Rates by Healthcare Provider Activity and Tier, Specialists
  • Figure 3.24: Average Half-Day Flat Rates by Healthcare Provider Tier, Primary Care Physicians
  • Figure 3.25: Average Half-Day Flat Rates by Healthcare Provider Activity and Tier, Primary Care Physicians
  • Figure 3.26: Minimum, Average and Maximum Half-Day Flat Rates by Healthcare Provider Tier, Primary Care Physicians

Healthcare Provider Fair-Market Value by Activity

  • Figure 3.27: Average Hourly Rates by Healthcare Provider Tier and Company Type, Clinical Consulting
  • Figure 3.28: Average Hourly Rates by Healthcare Provider Tier and Company Type, Commercial Consulting
  • Figure 3.29: Average Hourly Rates by Healthcare Provider Tier and Company Type, Promotional Speeches
  • Figure 3.30: Average Hourly Rates by Healthcare Provider Tier and Company Type, Scientific Speeches
  • Figure 3.31: Average Hourly Rates by Healthcare Provider Tier and Company Type, Leading an Advisory Board
  • Figure 3.32: Average Hourly Rates by Healthcare Provider Tier and Company Type, Participating in Advisory Board

Fair-Market Value Benchmarks for Middle East Healthcare Providers

  • Figure A.1: Middle East FMV Rates in Large Pharma
  • Figure A.1: (continued): Middle East FMV Rates in Large Pharma
  • Figure A.2: Middle East FMV Rates in Mid-Sized Pharma
  • Figure A.2: (continued): Middle East FMV Rates in Mid-Sized Pharma
  • Figure A.3: Middle East FMV Rates in Small Pharma
  • Figure A.3 (continued): Middle East FMV Rates in Small Pharma
  • Figure A.4: Middle East FMV Rates in CRO
  • Figure A.4: (continued): Middle East FMV Rates in CRO
  • Figure A.5: Middle East FMV Rates in Specialist
  • Figure A.5: (continued): Middle East FMV Rates in Specialist
  • Figure A.6: Middle East FMV Rates in Primary Care Physician
  • Figure A.6 (continued): Middle East FMV Rates in Primary Care Physician
Back to Top